Business Context and Reporting Period
Company: Aptevo Therapeutics Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 19, 2019
Reporting Period: Event date March 19, 2019; Signed March 22, 2019.
Context: The registrant is an emerging growth company headquartered in Seattle, Washington. The filing reports the entry into a material definitive agreement regarding its principal executive offices.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a specific contractual agreement rather than periodic financial performance.
Material Changes
On March 19, 2019, Aptevo entered into an Eighth Amendment to its Office Lease with Selig Real Estate Holdings Eight L.L.C. regarding its Seattle office space. Key changes include:
- Lease Term Extension: The lease term is extended by an additional 10 years, running through April 30, 2030.
- Rental Rate Adjustment: The base rental rate is set at $26.25 per square foot per year.
- Escalation Clause: Future annual increases will be based on the increase in Seattle's Consumer Price Index (CPI).
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. No specific risks or contingencies are detailed beyond the standard qualification that the summary of the lease amendment is not complete and is subject to the full terms of the attached Exhibit 10.1.
Investor Verification Checklist
- Verify the total square footage of the leased premises to calculate the total annual rent obligation.
- Review the full text of Exhibit 10.1 (Eighth Amendment to Office Lease) for termination rights, renewal options, and specific CPI calculation methodologies.
- Confirm the impact of the extended lease term on the company's long-term operating cash flow projections.
- Check subsequent filings for any further amendments or early termination of this agreement.